NCT00032890

Brief Summary

This study will determine whether glucosamine, chondroitin sulfate and/or the combination of glucosamine and chondroitin sulfate are more effective than placebo and whether the combination is more effective than glucosamine or chondroitin sulfate alone in the treatment of knee pain associated with osteoarthritis (OA) of the knee after six months of follow-up. These substances, marketed in the United States as dietary supplements, have been widely touted by the lay press and by anecdotal personal experience as effective in treating OA. To date, however, only a few small studies have been published in the worldwide literature. The study proposed herein has been carefully constructed to definitively determine the efficacy of these agents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,588

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2000

Typical duration for phase_3

Geographic Reach
1 country

16 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2000

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

April 5, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 8, 2002

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2004

Completed
Last Updated

January 21, 2009

Status Verified

November 1, 2006

First QC Date

April 5, 2002

Last Update Submit

January 20, 2009

Conditions

Keywords

osteoarthritisknee pain

Interventions

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
40 years and above, both genders, who have clinical and radiographic osteoarthritis symptomatic for at least six months.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (16)

University of Alabama at Birmingham

Birmingham, Alabama, 35294-7201, United States

Location

*University of Arizona Arthritis Center

Tucson, Arizona, 85724, United States

Location

*Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

Location

*University of California, Los Angeles

Los Angeles, California, 90095, United States

Location

*University of California San Francisco

San Francisco, California, 94110, United States

Location

Northwestern University

Chicago, Illinois, 60611, United States

Location

*Indiana University School of Medicine

Indianapolis, Indiana, 46202-5103, United States

Location

*Arthritis Research and Clinical Centers

Wichita, Kansas, 67214, United States

Location

University of Nebraska Medical Center

Omaha, Nebraska, 68198-3025, United States

Location

Hospital for Joint Diseases

New York, New York, 10003, United States

Location

*Case Western Reserve University

Beachwood, Ohio, 44122, United States

Location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

*University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

Arthritis Consultation Center

Dallas, Texas, 75231-4496, United States

Location

*University of Utah

Salt Lake City, Utah, 84132, United States

Location

Virginia Mason Research Center

Seattle, Washington, 98101, United States

Location

Related Publications (2)

  • Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb 23;354(8):795-808. doi: 10.1056/NEJMoa052771.

  • Sawitzke AD, Shi H, Finco MF, Dunlop DD, Bingham CO 3rd, Harris CL, Singer NG, Bradley JD, Silver D, Jackson CG, Lane NE, Oddis CV, Wolfe F, Lisse J, Furst DE, Reda DJ, Moskowitz RW, Williams HJ, Clegg DO. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum. 2008 Oct;58(10):3183-91. doi: 10.1002/art.23973.

MeSH Terms

Conditions

Osteoarthritis

Interventions

GlucosamineChondroitin SulfatesCelecoxib

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

HexosaminesAmino SugarsCarbohydratesChondroitinGlycosaminoglycansPolysaccharidesBenzenesulfonamidesSulfonamidesAmidesOrganic ChemicalsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsSulfonesSulfur CompoundsPyrazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED

Study Record Dates

First Submitted

April 5, 2002

First Posted

April 8, 2002

Study Start

April 1, 2000

Study Completion

February 1, 2004

Last Updated

January 21, 2009

Record last verified: 2006-11

Locations